3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Immunoglobulin Light-chain Amyloidosis
2
Amyloidosis
2
Waldenstrom Macroglobulinemia
1
Polycystic Ovary Syndrome
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Menstruation Disturbances
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hyperandrogenism
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Amyloidosis, Familial
1
Advanced Malignant Neoplasm
1
AA amyloidosis
1
Interventions
pembrolizumab
37
Paclitaxel
36
Carboplatin
31
Cyclophosphamide
22
Albumin-Bound Paclitaxel
20
atezolizumab
16
130-nm albumin-bound paclitaxel
16
Taxes
15
Doxorubicin
15
Cisplatin
13
Capecitabine
13
Nivolumab
10
Docetaxel
8
olaparib
7
Gemcitabine
6
Everolimus
6
talazoparib
5
durvalumab
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Bevacizumab
5
veliparib
4
spartalizumab
4
sacituzumab govitecan
4
pegfilgrastim
4
liposomal doxorubicin
4
eribulin
4
Specimen Handling
4
Immunoglobulin G
4
trilaciclib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Triple Negative Breast Neoplasms
×
Doxycycline
×
Clear all
No trials found.